SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q/A
(Amendment No. 1)
/x/ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES ACT
OF 1934
For the quarterly period ended: September 30, 1997
Commission file number: 1-11083
BOSTON SCIENTIFIC CORPORATION
-----------------------------
(Exact name of registrant as specified in its charter)
DELAWARE 04-2695240
-------- ----------
(State or other jurisdiction (I.R.S. Employer
of incorporation or organization) Identification No.)
One Boston Scientific Place, Natick, Massachusetts 01760-1537
- -------------------------------------------------- ----------
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: (508) 650-8000
--------------
- ------------------------------------------------------------------------------
Former name, former address and former fiscal year, if changed since last
report.
Indicate by check mark whether the registrant (1) has filed all reports
required to be filed by Section 13 or 15(d) of the Securities Exchange Act
of 1934 during the preceding 12 months (or for such shorter period that the
registrant was required to file such reports), and (2) has been subject to
such filing requirements for the past 90 days.
Yes X No
---
Indicate the number of shares outstanding of each of the issuer's classes of
common stock, as of the last practicable date.
Shares Outstanding
Class as of September 30, 1997
----- ------------------------
Common Stock, $.01 Par Value 194,616,695
- ------------------------------------------------------------------------------
I. INTRODUCTION.
This Amended Quarterly Report on Form 10-Q/A is filed solely to
correct a typographical error in the Article 5 Financial Data Schedule
included as Exhibit 27 in the Company's Quarterly Report on Form 10-Q for
the quarter ended September 30, 1997. The typographical error reflects a
negative rather than a positive entry in items entitled Income Continuing
and Net Income.
This amended Article 5 Financial Data Schedule replaces in its
entirety the Article 5 Financial Data Schedule previously filed.
OTHER INFORMATION
Item 6: Exhibits and Reports on Form 8-K
(a) Exhibits
Exhibit 27 - Financial Data Schedule
(b) The following reports on Form 8-K were filed during the
quarter ended September 30, 1997:
None.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized on December 22, 1997.
BOSTON SCIENTIFIC CORPORATION
By: /s/ Lawrence C. Best
Name: Lawrence C. Best
Title: Chief Financial Officer and Senior
Vice President - Finance and
Administration
<TABLE> <S> <C>
<ARTICLE> 5
<MULTIPLIER> 1,000
<S> <C>
<PERIOD-TYPE> 9-MOS
<FISCAL-YEAR-END> DEC-31-1997
<PERIOD-START> JAN-01-1997
<PERIOD-END> SEP-30-1997
<CASH> 54,269
<SECURITIES> 42,670
<RECEIVABLES> 385,555
<ALLOWANCES> 0
<INVENTORY> 362,964
<CURRENT-ASSETS> 1,000,583
<PP&E> 652,398
<DEPRECIATION> 196,315
<TOTAL-ASSETS> 1,857,831
<CURRENT-LIABILITIES> 667,733
<BONDS> 49,855
0
0
<COMMON> 1,956
<OTHER-SE> 1,019,737
<TOTAL-LIABILITY-AND-EQUITY> 1,857,831
<SALES> 1,379,053
<TOTAL-REVENUES> 1,379,053
<CGS> 388,419
<TOTAL-COSTS> 388,419
<OTHER-EXPENSES> 772,340
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 9,629
<INCOME-PRETAX> 215,712
<INCOME-TAX> 78,767
<INCOME-CONTINUING> 136,945
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> 136,945
<EPS-PRIMARY> 0.69
<EPS-DILUTED> 0.68
</TABLE>
